HUTCHMED
SHARE PRICE
204.00
CHANGE
7.00 ( 3.55%)
TICKER
HCM.L
Share Chart
Latest Articles for HCM.L
Hutchmed drugs stay on NRDL; Tazverik added to new insurance list
(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its...
Hutchmed completes Saffron trial enrolment, results due 2026
(Alliance News) - Hutchmed China Ltd on Wednesday said patient enrolment has been completed for its phase 3 Saffron trial evaluating the combination of Orpathys and Tagrisso in certain lung...
Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave
(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons....
Hutchmed China completes enrollment for phase three lung cancer trial
(Alliance News) - Hutchmed China Ltd on Wednesday said it has completed patient enrollment of Sanovo, a phase three trial of Orpathys and Tagrisso....